Raymond James & Associates’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-74,905	Closed	-$562K	–	4021
2024 Q2	$562K	Buy	74,905 +37,259	+99%	+$279K	﹤0.01%	2980
2024 Q1	$375K	Buy	+37,646	New	+$375K	﹤0.01%	3220
2023 Q4	–	Sell	-69,188	Closed	-$529K	–	3868
2023 Q3	$529K	Buy	+69,188	New	+$529K	﹤0.01%	2838